Circulating microRNAs and cardiomyocyte proliferation in heart failure patients related to 10 years survival

被引:4
|
作者
Wagh, Vilas [1 ,2 ]
Nguemo, Filomain [2 ]
Kiseleva, Zlata [3 ]
Mader, Robert M. [4 ]
Hescheler, Juergen [2 ]
Mohl, Werner [3 ,5 ]
机构
[1] Merck Res Labs, Boston, MA USA
[2] Univ Cologne, Inst Neurophysiol, Ctr Physiol & Pathophysiol, Cologne, Germany
[3] Med Univ Vienna, Dept Cardiac Surg, Vienna, Austria
[4] Med Univ Vienna, Dept Med 1, Vienna, Austria
[5] Med Univ Vienna, Lazarettgasse 12, A-1090 Vienna, Austria
来源
ESC HEART FAILURE | 2023年 / 10卷 / 06期
基金
奥地利科学基金会;
关键词
Cardiac regeneration; Circulating miRNAs; Embryonic recall; Heart failure; PICSO; CORONARY-SINUS INTERVENTIONS; STEM-CELL THERAPY; EMBRYONIC RECALL; BACK; REGENERATION; ACTIVATION; EXPRESSION; APOPTOSIS; KEY;
D O I
10.1002/ehf2.14516
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Mechanochemical signalling drives organogenesis and is highly conserved in mammal evolution. Regaining recovery in myocardial jeopardy by inducing principles linking cardiovascular therapy and clinical outcome has been the dream of scientists for decades. Concepts involving embryonic pathways to regenerate adult failing hearts became popular in the early millennium. Since then, abundant data on stem cell research have been published, never reaching widespread application in heart failure therapy. Another conceptual access, using mechanotransduction in cardiac veins to limit myocardial decay, is pressure-controlled intermittent coronary sinus occlusion (PICSO). Recently, we reported acute molecular signs and signals of PICSO activating regulatory miRNA and inducing cell proliferation mimicking cardiac development in adult failing hearts. According to a previously formulated hypothesis, 'embryonic recall', this study aimed to define molecular signals involved in endogenous heart repair during PICSO and study their relation to patient survival.Methods and results We previously reported a study on the acute molecular effects of PICSO in an observational non-randomized study. Eight out of the thirty-two patients with advanced heart failure undergoing cardiac resynchronization therapy (CRT) were treated with PICSO. Survival was monitored over 10 years, and coronary sinus blood samples were collected during intervention before and after 20 min and tested for miRNA signalling and proliferation when co-cultured with cardiomyocytes. A numerically lower death rate post-CRT and PICSO as compared with control CRT only, and a non-significant reduction in all-cause mortality risk of 42% was observed (37.5% vs. 54.0%, relative risk = 0.58, 95% confidence interval: 0.17-2.05; P = 0.402). Four miRNAs involved in cell cycle, proliferation, morphogenesis, embryonic development, and apoptosis significantly increased concomitantly in survivors and PICSO compared with a decrease in non-survivors (hsa-miR Let7b, P < 0.01; hsa-miR- 421, P < 0.006; hsa-miR 363-3p, P < 0.03 and hsa-miR 19b-3p P < 0.01). In contrast, three miRNAs involved in proliferation and survival, determining cell fate, and recycling endosomes decreased in survivors and PICSO (hsa miR 101-3p, P < 0.03; hsa-miR 25-3p, P < 002; hsa-miR 30d-5p P < 0.04). In vitro cellular proliferation increased in survivors and lowered in non-survivors showing a pattern distinction, discriminating longevity according to up to 10-year survival in heart failure patients.Conclusions This study proposes that generating regenerative signals observed during PICSO intervention relate to patient outcomes. Morphogenetic pathways induced by periods of flow reversal in cardiac veins in a domino-like pattern transform embryonic into regenerative signals. Studies supporting the conversion of mechanochemical signals into regenerative molecules during PICSO are warranted to substantiate predictive power on patient longevity, opening new therapeutic avenues in otherwise untreatable heart failure.
引用
收藏
页码:3559 / 3572
页数:14
相关论文
共 50 条
  • [1] Circulating microRNAs and outcome in patients with acute heart failure
    Goretti, E.
    Seronde, M. F.
    Vausort, M.
    Gayat, E.
    Thum, T.
    Solal, A. Cohen
    Wagner, D. R.
    Mebazaa, A.
    Devaux, Y.
    EUROPEAN HEART JOURNAL, 2014, 35 : 13 - 13
  • [2] Signature of circulating microRNAs in patients with acute heart failure
    Ovchinnikova, Ekaterina S.
    Schmitter, Daniela
    Vegter, Eline L.
    ter Maaten, Jozine M.
    Valente, Mattia A. E.
    Liu, Licette C. Y.
    van der Harst, Pim
    Pinto, Yigal M.
    de Boer, Rudolf A.
    Meyer, Sven
    Teerlink, John R.
    O'Connor, Christopher M.
    Metra, Marco
    Davison, Beth A.
    Bloomfield, Daniel M.
    Cotter, Gadi
    Cleland, John G.
    Mebazaa, Alexandre
    Laribi, Said
    Givertz, Michael M.
    Ponikowski, Piotr
    van der Meer, Peter
    van Veldhuisen, Dirk J.
    Voors, Adriaan A.
    Berezikov, Eugene
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (04) : 414 - 423
  • [3] Circulating microRNAs and outcome in patients with acute heart failure
    Goretti, E.
    Seronde, M. F.
    Vausort, M.
    Gayat, E.
    Thum, T.
    Cohen-Solal, A.
    Wagner, D. R.
    Mebazaa, A.
    Devaux, Yyvan
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 114 - 114
  • [4] Circulating microRNAs and outcome in patients with acute heart failure
    Goretti, E.
    Seronde, M. F.
    Vausort, M.
    Gayat, E.
    Thum, T.
    Cohen-Solal, A.
    Wagner, D. R.
    Mebazaa, A.
    Devaux, Y.
    CARDIOVASCULAR RESEARCH, 2014, 103
  • [5] Circulating microRNAs and Outcome in Patients with Acute Heart Failure
    Seronde, Marie-France
    Vausort, Melanie
    Gayat, Etienne
    Goretti, Emeline
    Ng, Leong L.
    Squire, Iain B.
    Vodovar, Nicolas
    Sadoune, Malha
    Samuel, Jane-Lise
    Thum, Thomas
    Solal, Alain Cohen
    Laribi, Said
    Plaisance, Patrick
    Wagner, Daniel R.
    Mebazaa, Alexandre
    Devaux, Yvan
    PLOS ONE, 2015, 10 (11):
  • [6] Signature of circulating microRNAs in patients with acute heart failure
    Ovchinnikova, Th E. Ekaterina
    Schmitter, D.
    Vegter, E.
    O' Connor, C.
    Bloomfield, D.
    Cotter, G.
    Mebazaa, A.
    Ponikowski, P.
    Voors, A.
    Berezikov, E.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 119 - 119
  • [7] Non-cardiomyocyte microRNAs in heart failure
    Tijsen, Anke J.
    Pinto, Yigal M.
    Creemers, Esther E.
    CARDIOVASCULAR RESEARCH, 2012, 93 (04) : 573 - 582
  • [8] Severe obstructive sleep apnea is associated with circulating microRNAs related to heart failure, myocardial ischemia, and cancer proliferation
    Freitas, Lunara S.
    Silveira, Andre C.
    Martins, Franco C.
    Costa-Hong, Valeria
    Lebkuchen, Adriana
    Cardozo, Karina H. M.
    Bernardes, Fernanda M.
    Bortolotto, Luiz A.
    Lorenzi-Filho, Geraldo
    Oliveira, Edilamar M.
    Drager, Luciano F.
    SLEEP AND BREATHING, 2020, 24 (04) : 1463 - 1472
  • [9] Severe obstructive sleep apnea is associated with circulating microRNAs related to heart failure, myocardial ischemia, and cancer proliferation
    Lunara S. Freitas
    André C. Silveira
    Franco C. Martins
    Valéria Costa-Hong
    Adriana Lebkuchen
    Karina H. M. Cardozo
    Fernanda M. Bernardes
    Luiz A. Bortolotto
    Geraldo Lorenzi-Filho
    Edilamar M. Oliveira
    Luciano F. Drager
    Sleep and Breathing, 2020, 24 : 1463 - 1472
  • [10] Cardiomyocyte apoptosis and survival in hypertensive patients with chronic heart failure
    González, A
    López, B
    Querejeta, R
    Larman, M
    Fortuño, MA
    Díez, J
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 82A - 82A